New Brain Cancer Drug Slows Tumor Progression

Published on June 5, 2023

Imagine you’re driving on the highway and suddenly, you hit a massive traffic jam. You’re stuck, going nowhere fast. Well, that’s what it feels like for patients with brain tumors. But now, there’s hope! A private drug developer called Servier Group has developed an experimental brain cancer treatment that is causing quite a ruckus. It turns out that this drug, called vorasidenib, has the power to slow down the progression of a specific type of brain tumor. In a field where progress has been stagnant for more than 20 years, this is a major breakthrough! Just like a construction worker on the highway who clears the lanes and makes way for smooth traffic, vorasidenib is doing the same by delaying the growth of these stubborn tumors.

Private drug developer Servier Group said on Sunday its experimental brain cancer treatment has considerably slowed the progression of a type of brain tumor, a positive in a field that has not seen progress for more than 20 years. The drug, vorasidenib, delayed the growth of…

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>